The availability of a growing variety of connected technologies such as continuous glucose monitoring systems (CGMs), blood pressure monitors, smart scales, digital stethoscopes, automated insulin delivery, connected insulin pens, and other digital health devices including consumer-facing fitness trackers are enabling individuals with diabetes to measure and self-manage their health directly using the data collected as they live their daily lives (10). The gene discussed is INS; the disease is diabetes mellitus.